Endovascular graft exclusion in patients with aortic dissection stanford type B: early and mid-term results
HE Yun,ZHAO Xiaohui,JIN Jun
DOI: https://doi.org/10.13201/j.issn.1001-1439.2012.12.014
2012-01-01
Journal of Clinical Cardiology
Abstract:Objective:To analysis the efficacy of endovascular graft exclusion(EVGE) in patients with aortic dissection type B. Method:From May 2007 to April 2012,endovascular treatment of 87 cases in our hospital aortic dissection Stanford type B: a clinical retrospective analysis of data.All patients with percutaneous femoral artery puncture and establishment of femoral arteries in endovascular graft exclusion for aortic road completed. Result:In-hospital data: surgery success rate 96.5%(84/87),average hospital time(6±2)d,average surgery time(115±35)min,which established into road time(6±2)min,operation completed into road processing time(4±2)min,postoperative CCU(13±5)h,postoperative hospital time(3±1)d,average comparison agent dosage(135±34)ml.Overall complication rate 17.2%,major morbidity 3.4%,minor complication rate 13.8%,hospital mortality rates 2.2%.Follow-up data after stent-graft: as of May 2011,all patient follow-up time of(42±17) months,range(1-60) months,and follow up 96.6%.Thirty days,1 year,2 year,3 year,and 4 year survival rates were 97.7%,95.2%,90.5%,87.0%,and 85.7%,respectively.Vena thrombosis was 93.1%(81/87).Overall complication rate was 11.9%,and related follow-up endovascular CFR was 2.4%. Conclusion:Endovascular treatments of aortic dissection Stanford type B have good short-and medium-term effects.